We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $7.72B
1-Year Est. Return 32.88%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
AUM
$7.72B
AUM Growth
+$1.97B
Cap. Flow
+$1.58B
Cap. Flow %
20.47%
Top 10 Hldgs %
3.84%
Holding
4,912
New
1,139
Increased
1,694
Reduced
1,253
Closed
825

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$41.2M
2
NFLX icon
Netflix
NFLX
+$35.5M
3
ICE icon
Intercontinental Exchange
ICE
+$29.7M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$29.4M
5
PEP icon
PepsiCo
PEP
+$28.7M

Sector Composition

Rank Sector Weight
1 Technology 17.09%
2 Financials 15.06%
3 Industrials 13.48%
4 Healthcare 12%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KWY
3476
Kingsway Corp
KWY
$279M
$116K ﹤0.01%
+11,176
New +$121K
OSG
3477
Octave Specialty Group
OSG
$203M
$116K ﹤0.01%
18,657
-98,254
-84% -$512K
INO icon
3478
Inovio Pharmaceuticals
INO
$128M
$116K ﹤0.01%
105,833
-106,844
-50% -$127K
IRWD icon
3479
Ironwood Pharmaceuticals
IRWD
$720M
$116K ﹤0.01%
+27,646
New +$107K
EH
3480
EHang Holdings
EH
$350M
$116K ﹤0.01%
+17,727
New +$165K
EXFY icon
3481
Expensify
EXFY
$204M
$116K ﹤0.01%
+64,764
New +$72.7K
CORD
3482
T-REX 2X Inverse CRWV Daily Target ETF
CORD
$27.7M
$116K ﹤0.01%
+21,090
New +$133K
QBTZ
3483
Defiance Daily Target 2x Short QBTS ETF
QBTZ
$32M
$115K ﹤0.01%
+6,031
New +$458K
CNVS icon
3484
Cineverse
CNVS
$50.4M
$115K ﹤0.01%
38,631
+7,538
+24% +$19.4K
AARD
3485
Aardvark Therapeutics
AARD
$118M
$115K ﹤0.01%
19,888
-27
-0.1% -$126
MYO icon
3486
Myomo
MYO
$58.6M
$114K ﹤0.01%
110,028
+6,933
+7% +$6.76K
POWW icon
3487
Outdoor Holding Co
POWW
$254M
$114K ﹤0.01%
50,013
-5,178
-9% -$10.7K
EIDO icon
3488
iShares MSCI Indonesia ETF
EIDO
$486M
$114K ﹤0.01%
+10,082
New +$141K
CING icon
3489
Cingulate
CING
$76.2M
$114K ﹤0.01%
20,818
-32,685
-61% -$165K
NRDY icon
3490
Nerdy
NRDY
$76.2M
$114K ﹤0.01%
8,273
-6,028
-42% -$78.7K
EOD
3491
Allspring Global Dividend Opportunity Fund
EOD
$276M
$113K ﹤0.01%
+17,254
New +$110K
DH icon
3492
Definitive Healthcare
DH
$102M
$112K ﹤0.01%
135,370
+111,863
+476% +$102K
GANX icon
3493
Gain Therapeutics
GANX
$76.8M
$112K ﹤0.01%
+55,294
New +$102K
VYGR icon
3494
Voyager Therapeutics
VYGR
$190M
$112K ﹤0.01%
+32,058
New +$122K
CVRX icon
3495
CVRx
CVRX
$81M
$112K ﹤0.01%
21,825
-404
-2% -$2.61K
EFT
3496
Eaton Vance Floating-Rate Income Trust
EFT
$280M
$112K ﹤0.01%
+10,362
New +$112K
SPRO icon
3497
Spero Therapeutics
SPRO
$65.8M
$112K ﹤0.01%
+50,536
New +$132K
PFL
3498
PIMCO Income Strategy Fund
PFL
$361M
$112K ﹤0.01%
+14,170
New +$111K
DHF
3499
BNY Mellon High Yield Strategies Fund
DHF
$165M
$111K ﹤0.01%
45,924
+29,817
+185% +$72.2K
SRL icon
3500
Scully Royalty
SRL
$81.1M
$111K ﹤0.01%
18,140
+2,143
+13% +$15K

Similar funds

XTX Topco's Q2 2026 Portfolio in Review

As of Q2 2026, XTX Topco held 4,912 positions worth $7.72B, up 34% from $5.75B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.

XTX Topco deployed $1.58B of net new capital in Q2 2026, opening 1,139 new positions and adding to 1,694 existing holdings. Its largest new stake was Netflix: 403,127 shares worth $28.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $29.9M trimmed.

  • XTX Topco's largest Q2 2026 buy was Netflix: 403,127 shares worth $28.8M.
  • XTX Topco added most to Chevron in Q2 2026, an estimated $41.2M increase.
  • XTX Topco's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.9M.
  • XTX Topco fully exited iShares MSCI South Korea ETF in Q2 2026, selling an estimated $35.4M.
  • XTX Topco's ten largest holdings make up 3.8% of its $7.72B portfolio in Q2 2026.
  • XTX Topco opened 1,139 new positions and closed 825 in Q2 2026.
  • XTX Topco's portfolio value rose 34% quarter-over-quarter to $7.72B.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.